Hillevax

Hillevax EBITDA

Delisted

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Hillevax (HLVX) as of Nov 20, 2026 is -155.29 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -133.35 M USD — a change of 16.46% (lower).

EBITDA

-155.29 MUSD

YoY

16.46%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Hillevax is 2024 -155.29 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Hillevax was 2023 -133.35 M USD. It decreases by 16.46% lower compared to the previous year.

The Hillevax EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
-633,000.00 USD
Jan 1, 2020
-1.30 M USD
Jan 1, 2021
-53.43 M USD
Jan 1, 2022
-65.11 M USD
Jan 1, 2023
-133.35 M USD
Jan 1, 2024
-155.29 M USD
The Hillevax EBITDA history
YEAREBITDAYoY
-155.29 MUSD+16.46%
-133.35 MUSD+104.79%
-65.11 MUSD+21.88%
-53.43 MUSD+4,025.56%
-1.30 MUSD+104.58%
-633,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hillevax Stock analysis

What does Hillevax do? HilleVax, Inc. develops and commercializes novel vaccines, focusing on HIL-214, a bivalent virus-like particle (VLP) vaccine candidate for norovirus-induced acute gastroenteritis. The vaccine combines VLPs for norovirus genotypes GI.1 and GII.4 with an aluminum hydroxide adjuvant to enhance immune response. HIL-214 targets moderate-to-severe cases of norovirus infection, which causes symptoms like diarrhea, vomiting, and dehydration. The company's primary revenue stream will come from the future commercialization of HIL-214 after regulatory approval, with potential sales to healthcare providers and public health programs. Hillevax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hillevax stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Hillevax is -155.29 M USD in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Hillevax changed from -133.35 M USD to -155.29 M USD, representing a 16.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Hillevax since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Hillevax historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Hillevax

All Key Metrics — Hillevax